Lantheus Holdings will host a Q1 2025 financial results conference call on May 7, 2025.
Quiver AI Summary
Lantheus Holdings, Inc. announced it will host a conference call and webcast on May 7, 2025, at 8:00 a.m. ET to discuss its financial and operational results for the first quarter of 2025. Participants can register for the event online and are encouraged to do so 15 minutes in advance. A replay will be available on the company's website shortly after the event concludes and will remain accessible for at least 30 days. Lantheus, a leader in the radiopharmaceutical sector, has been providing innovative solutions for nearly 70 years and is headquartered in Massachusetts, with additional offices in New Jersey, Canada, and Sweden.
Potential Positives
- The company is actively engaging investors and stakeholders by hosting a conference call and webcast to discuss its financial and operating results for Q1 2025.
- Lantheus Holdings is positioned as a leader in the radiopharmaceutical sector, emphasizing its commitment to improving patient outcomes through innovative science.
- The event provides an opportunity for increased transparency and communication with investors, potentially enhancing trust and interest in the company.
Potential Negatives
- None
FAQ
When is the Lantheus conference call scheduled?
The Lantheus conference call is scheduled for Wednesday, May 7, 2025, at 8:00 a.m. ET.
How can I access the Lantheus webcast?
You can access the Lantheus webcast by registering online at https://investor.lantheus.com/news-events/calendar-of-events.
Will there be a replay of the conference call?
Yes, a replay will be available approximately two hours after the webcast and archived for at least 30 days.
Where is Lantheus headquartered?
Lantheus is headquartered in Bedford, Massachusetts, with additional offices in New Jersey, Canada, and Sweden.
What is Lantheus known for?
Lantheus is known for being a leading radiopharmaceutical-focused company delivering solutions to improve patient outcomes.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$LNTH Congressional Stock Trading
Members of Congress have traded $LNTH stock 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $LNTH stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 4 purchases worth up to $60,000 on 01/28, 01/13, 01/08, 01/07 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$LNTH Insider Trading Activity
$LNTH insiders have traded $LNTH stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $LNTH stock by insiders over the last 6 months:
- MARY ANNE HEINO has made 0 purchases and 10 sales selling 64,596 shares for an estimated $6,012,151.
- ROBERT J. JR. MARSHALL (CFO and Treasurer) has made 0 purchases and 2 sales selling 20,000 shares for an estimated $1,817,200.
- PAUL BLANCHFIELD (President) has made 0 purchases and 2 sales selling 4,084 shares for an estimated $363,532.
- JAMES H THRALL sold 1,000 shares for an estimated $94,760
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LNTH Hedge Fund Activity
We have seen 254 institutional investors add shares of $LNTH stock to their portfolio, and 233 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC added 2,610,118 shares (+72.7%) to their portfolio in Q4 2024, for an estimated $233,501,156
- FARALLON CAPITAL MANAGEMENT LLC added 2,361,000 shares (+79.9%) to their portfolio in Q4 2024, for an estimated $211,215,060
- LAZARD ASSET MANAGEMENT LLC removed 839,023 shares (-77.5%) from their portfolio in Q4 2024, for an estimated $75,058,997
- HOOD RIVER CAPITAL MANAGEMENT LLC removed 453,255 shares (-37.4%) from their portfolio in Q4 2024, for an estimated $40,548,192
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 435,445 shares (+40.5%) to their portfolio in Q4 2024, for an estimated $38,954,909
- LORD, ABBETT & CO. LLC removed 431,107 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $38,566,832
- UBS GROUP AG added 427,410 shares (+681.3%) to their portfolio in Q4 2024, for an estimated $38,236,098
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$LNTH Analyst Ratings
Wall Street analysts have issued reports on $LNTH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 12/18/2024
To track analyst ratings and price targets for $LNTH, check out Quiver Quantitative's $LNTH forecast page.
Full Release
BEDFORD, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, May 7, 2025, to discuss its financial and operating results for the first quarter of 2025.
To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events . To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for nearly 70 years. For more information, visit www.lantheus.com .
Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
[email protected]
Melissa Downs
Executive Director, External Communications
646-975-2533
[email protected]
